Announcements Trials
Browse Landscape

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Neuroendocrine Tumors 5Carcinoma, Hepatocellular 5Stomach Neoplasms 4Esophageal Neoplasms 4Weight Loss 3Prostatic Neoplasms 3Pancreatic Neoplasms 3Breast Neoplasms 3Ovarian Neoplasms 2Neoplasms 2Neoplasm Metastasis 2Malnutrition 2Intestinal Obstruction 2Duodenal Neoplasms 2Diarrhea 2Colorectal Neoplasms 2Carcinoid Tumor 2Adenoma, Islet Cell 2Acromegaly 2Waldenstrom Macroglobulinemia 1Vulvar Neoplasms 1Vomiting 1Vipoma 1Vaginal Neoplasms 1Uterine Cervical Neoplasms 1Unspecified Adult Solid Tumor, Protocol Specific 1Somatostatinoma 1Serotonin Syndrome 1Sarcoma 1Rectal Neoplasms 1

Interventions

Octreotide 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Gastric NET × Octreotide × Clear all
NCT03812939 2019-01-23

Recurrence Rates of Type I Gastric Neuroendocrine Tumors Treated With Long-acting Somatostatin Analogs

Peking Union Medical College Hospital

Unknown
30 enrolled
Gastrointestinal

Gastric NET

Data powered by HemOnc (CC BY 4.0) Colophon âš¡